Immunotherapy in Non-Small Cell Lung Cancer. Which Patients and at Which Stage?

Am J Respir Crit Care Med. 2019 May 15;199(10):1277-1279. doi: 10.1164/rccm.201810-1930RR.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Immunotherapy
  • Lung Neoplasms*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab